APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rasagiline Mesylate Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Rasagiline Mesylate Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025197 pages

Choose your research edition.

Industry ResearchRasagiline Mesylate Tablets Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Rasagiline Mesylate Tablets Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Rasagiline Mesylate Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rasagiline Mesylate Tablets Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Rasagiline Mesylate Tablets Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Rasagiline Mesylate Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Rasagiline Mesylate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Rasagiline Mesylate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rasagiline Mesylate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Rasagiline Mesylate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Rasagiline Mesylate Tablets include Teva Pharmaceutical, Sun Pharmaceutical, Sandoz, Mylan, Takeda Pharmaceutical, Taj Pharma, Orchid Pharma, Natco Pharma and Lundbeck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Rasagiline Mesylate Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Rasagiline Mesylate Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Rasagiline Mesylate Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Rasagiline Mesylate Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Rasagiline Mesylate Tablets Segment by Company

Teva Pharmaceutical

Sun Pharmaceutical

Sandoz

Mylan

Takeda Pharmaceutical

Taj Pharma

Orchid Pharma

Natco Pharma

Lundbeck

Intas Pharmaceuticals

Apotex

Alkem Laboratories

Ajanta Pharma

Rasagiline Mesylate Tablets Segment by Type

0.5 mg/Pcs

1 mg/Pcs

Rasagiline Mesylate Tablets Segment by Application

40-65 Years Old

Under 40 Years Old

Above 65 Years Old

Rasagiline Mesylate Tablets Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rasagiline Mesylate Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rasagiline Mesylate Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rasagiline Mesylate Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Rasagiline Mesylate Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Rasagiline Mesylate Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Rasagiline Mesylate Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Rasagiline Mesylate Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Rasagiline Mesylate Tablets Industry Trends Table 2. Rasagiline Mesylate Tablets Industry Drivers Table 3. Rasagiline Mesylate Tablets Industry Opportunities and Challenges Table 4. Rasagiline Mesylate Tablets Industry Restraints Table 5. Global Rasagiline Mesylate Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Rasagiline Mesylate Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Rasagiline Mesylate Tablets Sales by Manufacturers (W Pcs) & (2021-2026) Table 8. Global Rasagiline Mesylate Tablets Sales Market Share by Manufacturers Table 9. Global Rasagiline Mesylate Tablets Average Sales Price (US$/K Pcs) of Manufacturers (2021-2026) Table 10. Global Rasagiline Mesylate Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Rasagiline Mesylate Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Rasagiline Mesylate Tablets Manufacturers, Product Type & Application Table 13. Global Rasagiline Mesylate Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Rasagiline Mesylate Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 0.5 mg/Pcs Table 17. Major Manufacturers of 1 mg/Pcs Table 18. Global Rasagiline Mesylate Tablets Sales by Type 2021 VS 2025 VS 2032 (W Pcs) Table 19. Global Rasagiline Mesylate Tablets Sales by Type (2021-2026) & (W Pcs) Table 20. Global Rasagiline Mesylate Tablets Sales by Type (2027-2032) & (W Pcs) Table 21. Global Rasagiline Mesylate Tablets Sales Market Share by Type (2021-2026) Table 22. Global Rasagiline Mesylate Tablets Sales Market Share by Type (2027-2032) Table 23. Global Rasagiline Mesylate Tablets Revenue by Type 2021 VS 2025 VS 2032 (W Pcs) Table 24. Global Rasagiline Mesylate Tablets Revenue by Type (2021-2026) & (W Pcs) Table 25. Global Rasagiline Mesylate Tablets Revenue by Type (2027-2032) & (W Pcs) Table 26. Global Rasagiline Mesylate Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Rasagiline Mesylate Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of 40-65 Years Old Table 29. Major Manufacturers of Under 40 Years Old Table 30. Major Manufacturers of Above 65 Years Old Table 31. Global Rasagiline Mesylate Tablets Sales by Application 2021 VS 2025 VS 2032 (W Pcs) Table 32. Global Rasagiline Mesylate Tablets Sales by Application (2021-2026) & (W Pcs) Table 33. Global Rasagiline Mesylate Tablets Sales by Application (2027-2032) & (W Pcs) Table 34. Global Rasagiline Mesylate Tablets Sales Market Share by Application (2021-2026) Table 35. Global Rasagiline Mesylate Tablets Sales Market Share by Application (2027-2032) Table 36. Global Rasagiline Mesylate Tablets Revenue by Application 2021 VS 2025 VS 2032 (W Pcs) Table 37. Global Rasagiline Mesylate Tablets Revenue by Application (2021-2026) & (W Pcs) Table 38. Global Rasagiline Mesylate Tablets Revenue by Application (2027-2032) & (W Pcs) Table 39. Global Rasagiline Mesylate Tablets Revenue Market Share by Application (2021-2026) Table 40. Global Rasagiline Mesylate Tablets Revenue Market Share by Application (2027-2032) Table 41. Global Rasagiline Mesylate Tablets Sales by Region: 2021 VS 2025 VS 2032 (W Pcs) Table 42. Global Rasagiline Mesylate Tablets Sales by Region (2021-2026) & (W Pcs) Table 43. Global Rasagiline Mesylate Tablets Sales Market Share by Region (2021-2026) Table 44. Global Rasagiline Mesylate Tablets Sales Forecasted by Region (2027-2032) & (W Pcs) Table 45. Global Rasagiline Mesylate Tablets Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Rasagiline Mesylate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Pcs) Table 47. North America Rasagiline Mesylate Tablets Sales by Country (2021-2026) & (W Pcs) Table 48. North America Rasagiline Mesylate Tablets Sales by Country (2027-2032) & (W Pcs) Table 49. Europe Rasagiline Mesylate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Pcs) Table 50. Europe Rasagiline Mesylate Tablets Sales by Country (2021-2026) & (W Pcs) Table 51. Europe Rasagiline Mesylate Tablets Sales by Country (2027-2032) & (W Pcs) Table 52. Asia Pacific Rasagiline Mesylate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Pcs) Table 53. Asia Pacific Rasagiline Mesylate Tablets Sales by Country (2021-2026) & (W Pcs) Table 54. Asia Pacific Rasagiline Mesylate Tablets Sales by Country (2027-2032) & (W Pcs) Table 55. South America, Middle East and Africa Rasagiline Mesylate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Pcs) Table 56. South America, Middle East and Africa Rasagiline Mesylate Tablets Sales by Country (2021-2026) & (W Pcs) Table 57. South America, Middle East and Africa Rasagiline Mesylate Tablets Sales by Country (2027-2032) & (W Pcs) Table 58. Global Rasagiline Mesylate Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Rasagiline Mesylate Tablets Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Rasagiline Mesylate Tablets Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Rasagiline Mesylate Tablets Revenue Market Share by Region (2021-2026) Table 62. Global Rasagiline Mesylate Tablets Revenue Market Share by Region (2027-2032) Table 63. Teva Pharmaceutical Company Information Table 64. Teva Pharmaceutical Business Overview Table 65. Teva Pharmaceutical Rasagiline Mesylate Tablets Sales (W Pcs), Price (US$/K Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Teva Pharmaceutical Rasagiline Mesylate Tablets Product Portfolio Table 67. Teva Pharmaceutical Recent Development Table 68. Sun Pharmaceutical Company Information Table 69. Sun Pharmaceutical Business Overview Table 70. Sun Pharmaceutical Rasagiline Mesylate Tablets Sales (W Pcs), Price (US$/K Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sun Pharmaceutical Rasagiline Mesylate Tablets Product Portfolio Table 72. Sun Pharmaceutical Recent Development Table 73. Sandoz Company Information Table 74. Sandoz Business Overview Table 75. Sandoz Rasagiline Mesylate Tablets Sales (W Pcs), Price (US$/K Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Sandoz Rasagiline Mesylate Tablets Product Portfolio Table 77. Sandoz Recent Development Table 78. Mylan Company Information Table 79. Mylan Business Overview Table 80. Mylan Rasagiline Mesylate Tablets Sales (W Pcs), Price (US$/K Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Mylan Rasagiline Mesylate Tablets Product Portfolio Table 82. Mylan Recent Development Table 83. Takeda Pharmaceutical Company Information Table 84. Takeda Pharmaceutical Business Overview Table 85. Takeda Pharmaceutical Rasagiline Mesylate Tablets Sales (W Pcs), Price (US$/K Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Takeda Pharmaceutical Rasagiline Mesylate Tablets Product Portfolio Table 87. Takeda Pharmaceutical Recent Development Table 88. Taj Pharma Company Information Table 89. Taj Pharma Business Overview Table 90. Taj Pharma Rasagiline Mesylate Tablets Sales (W Pcs), Price (US$/K Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Taj Pharma Rasagiline Mesylate Tablets Product Portfolio Table 92. Taj Pharma Recent Development Table 93. Orchid Pharma Company Information Table 94. Orchid Pharma Business Overview Table 95. Orchid Pharma Rasagiline Mesylate Tablets Sales (W Pcs), Price (US$/K Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Orchid Pharma Rasagiline Mesylate Tablets Product Portfolio Table 97. Orchid Pharma Recent Development Table 98. Natco Pharma Company Information Table 99. Natco Pharma Business Overview Table 100. Natco Pharma Rasagiline Mesylate Tablets Sales (W Pcs), Price (US$/K Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Natco Pharma Rasagiline Mesylate Tablets Product Portfolio Table 102. Natco Pharma Recent Development Table 103. Lundbeck Company Information Table 104. Lundbeck Business Overview Table 105. Lundbeck Rasagiline Mesylate Tablets Sales (W Pcs), Price (US$/K Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Lundbeck Rasagiline Mesylate Tablets Product Portfolio Table 107. Lundbeck Recent Development Table 108. Intas Pharmaceuticals Company Information Table 109. Intas Pharmaceuticals Business Overview Table 110. Intas Pharmaceuticals Rasagiline Mesylate Tablets Sales (W Pcs), Price (US$/K Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Intas Pharmaceuticals Rasagiline Mesylate Tablets Product Portfolio Table 112. Intas Pharmaceuticals Recent Development Table 113. Apotex Company Information Table 114. Apotex Business Overview Table 115. Apotex Rasagiline Mesylate Tablets Sales (W Pcs), Price (US$/K Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Apotex Rasagiline Mesylate Tablets Product Portfolio Table 117. Apotex Recent Development Table 118. Alkem Laboratories Company Information Table 119. Alkem Laboratories Business Overview Table 120. Alkem Laboratories Rasagiline Mesylate Tablets Sales (W Pcs), Price (US$/K Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Alkem Laboratories Rasagiline Mesylate Tablets Product Portfolio Table 122. Alkem Laboratories Recent Development Table 123. Ajanta Pharma Company Information Table 124. Ajanta Pharma Business Overview Table 125. Ajanta Pharma Rasagiline Mesylate Tablets Sales (W Pcs), Price (US$/K Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Ajanta Pharma Rasagiline Mesylate Tablets Product Portfolio Table 127. Ajanta Pharma Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. Rasagiline Mesylate Tablets Distributors List Table 131. Rasagiline Mesylate Tablets Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Rasagiline Mesylate Tablets Product Image Figure 2. Global Rasagiline Mesylate Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rasagiline Mesylate Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Rasagiline Mesylate Tablets Sales (2021-2032) & (W Pcs) Figure 5. Global Rasagiline Mesylate Tablets Average Price (US$/K Pcs) & (2021-2032) Figure 6. Global Top 5 and 10 Rasagiline Mesylate Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 0.5 mg/Pcs Image Figure 9. 1 mg/Pcs Image Figure 10. Global Rasagiline Mesylate Tablets Sales by Type (2021 VS 2025 VS 2032) & (W Pcs) Figure 11. Global Rasagiline Mesylate Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Rasagiline Mesylate Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Rasagiline Mesylate Tablets Revenue by Type (2021 VS 2025 VS 2032) & (W Pcs) Figure 14. Global Rasagiline Mesylate Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Rasagiline Mesylate Tablets Revenue Market Share by Type (2021-2032) Figure 16. 40-65 Years Old Image Figure 17. Under 40 Years Old Image Figure 18. Above 65 Years Old Image Figure 19. Global Rasagiline Mesylate Tablets Sales by Application (2021 VS 2025 VS 2032) & (W Pcs) Figure 20. Global Rasagiline Mesylate Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Rasagiline Mesylate Tablets Sales Market Share by Application (2021-2032) Figure 22. Global Rasagiline Mesylate Tablets Revenue by Application (2021 VS 2025 VS 2032) & (W Pcs) Figure 23. Global Rasagiline Mesylate Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Rasagiline Mesylate Tablets Revenue Market Share by Application (2021-2032) Figure 25. North America Rasagiline Mesylate Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 26. North America Rasagiline Mesylate Tablets Sales Market Share by Country (2021-2032) Figure 27. U.S. Rasagiline Mesylate Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 28. Canada Rasagiline Mesylate Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 29. Mexico Rasagiline Mesylate Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 30. Europe Rasagiline Mesylate Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 31. Europe Rasagiline Mesylate Tablets Sales Market Share by Country (2021-2032) Figure 32. Germany Rasagiline Mesylate Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 33. France Rasagiline Mesylate Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 34. U.K. Rasagiline Mesylate Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 35. Italy Rasagiline Mesylate Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 36. Netherlands Rasagiline Mesylate Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 37. Asia Pacific Rasagiline Mesylate Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 38. Asia Pacific Rasagiline Mesylate Tablets Sales Market Share by Country (2021-2032) Figure 39. China Rasagiline Mesylate Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 40. Japan Rasagiline Mesylate Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 41. South Korea Rasagiline Mesylate Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 42. Southeast Asia Rasagiline Mesylate Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 43. India Rasagiline Mesylate Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 44. Australia Rasagiline Mesylate Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 45. South America, Middle East and Africa Rasagiline Mesylate Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 46. South America, Middle East and Africa Rasagiline Mesylate Tablets Sales Market Share by Country (2021-2032) Figure 47. Brazil Rasagiline Mesylate Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 48. South Africa Rasagiline Mesylate Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 49. Saudi Arabia Rasagiline Mesylate Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 50. Turkey Rasagiline Mesylate Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 51. Argentina Rasagiline Mesylate Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 52. UAE Rasagiline Mesylate Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 53. Egypt Rasagiline Mesylate Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 54. Chile Rasagiline Mesylate Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 55. Global Rasagiline Mesylate Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Rasagiline Mesylate Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Rasagiline Mesylate Tablets Revenue (2021-2032) & (US$ Million) Figure 58. North America Rasagiline Mesylate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Rasagiline Mesylate Tablets Revenue (2021-2032) & (US$ Million) Figure 60. Europe Rasagiline Mesylate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Rasagiline Mesylate Tablets Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Rasagiline Mesylate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Rasagiline Mesylate Tablets Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Rasagiline Mesylate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Rasagiline Mesylate Tablets Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Rasagiline Mesylate Tablets Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 0.5 mg/Pcs
  • 1 mg/Pcs
Applications
  • 40-65 Years Old
  • Under 40 Years Old
  • Above 65 Years Old
Companies covered
  • Teva Pharmaceutical
  • Sun Pharmaceutical
  • Sandoz
  • Mylan
  • Takeda Pharmaceutical
  • Taj Pharma
  • Orchid Pharma
  • Natco Pharma
  • Lundbeck
  • Intas Pharmaceuticals
  • Apotex
  • Alkem Laboratories
  • Ajanta Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Rasagiline Mesylate Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Rasagiline Mesylate Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Rasagiline Mesylate Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Rasagiline Mesylate Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Rasagiline Mesylate Tablets Market Dynamics
  1. 2.1 Rasagiline Mesylate Tablets Industry Trends
  2. 2.2 Rasagiline Mesylate Tablets Industry Drivers
  3. 2.3 Rasagiline Mesylate Tablets Industry Opportunities and Challenges
  4. 2.4 Rasagiline Mesylate Tablets Industry Restraints
3 Rasagiline Mesylate Tablets Market by Manufacturers
  1. 3.1 Global Rasagiline Mesylate Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Rasagiline Mesylate Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Rasagiline Mesylate Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Rasagiline Mesylate Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Rasagiline Mesylate Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Rasagiline Mesylate Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Rasagiline Mesylate Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Rasagiline Mesylate Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Rasagiline Mesylate Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Rasagiline Mesylate Tablets Tier 1, Tier 2, and Tier 3
4 Rasagiline Mesylate Tablets Market by Type
  1. 4.1 Rasagiline Mesylate Tablets Type Introduction
  2. 4.1.1 0.5 mg/Pcs
  3. 4.1.2 1 mg/Pcs
  4. 4.2 Global Rasagiline Mesylate Tablets Sales by Type
  5. 4.2.1 Global Rasagiline Mesylate Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Rasagiline Mesylate Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Rasagiline Mesylate Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Rasagiline Mesylate Tablets Revenue by Type
  9. 4.3.1 Global Rasagiline Mesylate Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Rasagiline Mesylate Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Rasagiline Mesylate Tablets Revenue Market Share by Type (2021-2032)
5 Rasagiline Mesylate Tablets Market by Application
  1. 5.1 Rasagiline Mesylate Tablets Application Introduction
  2. 5.1.1 40-65 Years Old
  3. 5.1.2 Under 40 Years Old
  4. 5.1.3 Above 65 Years Old
  5. 5.2 Global Rasagiline Mesylate Tablets Sales by Application
  6. 5.2.1 Global Rasagiline Mesylate Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Rasagiline Mesylate Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Rasagiline Mesylate Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Rasagiline Mesylate Tablets Revenue by Application
  10. 5.3.1 Global Rasagiline Mesylate Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Rasagiline Mesylate Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Rasagiline Mesylate Tablets Revenue Market Share by Application (2021-2032)
6 Global Rasagiline Mesylate Tablets Sales by Region
  1. 6.1 Global Rasagiline Mesylate Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Rasagiline Mesylate Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Rasagiline Mesylate Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Rasagiline Mesylate Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Rasagiline Mesylate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Rasagiline Mesylate Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Rasagiline Mesylate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Rasagiline Mesylate Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Rasagiline Mesylate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Rasagiline Mesylate Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Rasagiline Mesylate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Rasagiline Mesylate Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Rasagiline Mesylate Tablets Revenue by Region
  1. 7.1 Global Rasagiline Mesylate Tablets Revenue by Region
  2. 7.1.1 Global Rasagiline Mesylate Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Rasagiline Mesylate Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Rasagiline Mesylate Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Rasagiline Mesylate Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Rasagiline Mesylate Tablets Revenue (2021-2032)
  8. 7.2.2 North America Rasagiline Mesylate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Rasagiline Mesylate Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Rasagiline Mesylate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Rasagiline Mesylate Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Rasagiline Mesylate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Rasagiline Mesylate Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Rasagiline Mesylate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical
  2. 8.1.1 Teva Pharmaceutical Company Information
  3. 8.1.2 Teva Pharmaceutical Business Overview
  4. 8.1.3 Teva Pharmaceutical Rasagiline Mesylate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Rasagiline Mesylate Tablets Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Recent Developments
  7. 8.2 Sun Pharmaceutical
  8. 8.2.1 Sun Pharmaceutical Company Information
  9. 8.2.2 Sun Pharmaceutical Business Overview
  10. 8.2.3 Sun Pharmaceutical Rasagiline Mesylate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sun Pharmaceutical Rasagiline Mesylate Tablets Product Portfolio
  12. 8.2.5 Sun Pharmaceutical Recent Developments
  13. 8.3 Sandoz
  14. 8.3.1 Sandoz Company Information
  15. 8.3.2 Sandoz Business Overview
  16. 8.3.3 Sandoz Rasagiline Mesylate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sandoz Rasagiline Mesylate Tablets Product Portfolio
  18. 8.3.5 Sandoz Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Rasagiline Mesylate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Rasagiline Mesylate Tablets Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Takeda Pharmaceutical
  26. 8.5.1 Takeda Pharmaceutical Company Information
  27. 8.5.2 Takeda Pharmaceutical Business Overview
  28. 8.5.3 Takeda Pharmaceutical Rasagiline Mesylate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Takeda Pharmaceutical Rasagiline Mesylate Tablets Product Portfolio
  30. 8.5.5 Takeda Pharmaceutical Recent Developments
  31. 8.6 Taj Pharma
  32. 8.6.1 Taj Pharma Company Information
  33. 8.6.2 Taj Pharma Business Overview
  34. 8.6.3 Taj Pharma Rasagiline Mesylate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Taj Pharma Rasagiline Mesylate Tablets Product Portfolio
  36. 8.6.5 Taj Pharma Recent Developments
  37. 8.7 Orchid Pharma
  38. 8.7.1 Orchid Pharma Company Information
  39. 8.7.2 Orchid Pharma Business Overview
  40. 8.7.3 Orchid Pharma Rasagiline Mesylate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Orchid Pharma Rasagiline Mesylate Tablets Product Portfolio
  42. 8.7.5 Orchid Pharma Recent Developments
  43. 8.8 Natco Pharma
  44. 8.8.1 Natco Pharma Company Information
  45. 8.8.2 Natco Pharma Business Overview
  46. 8.8.3 Natco Pharma Rasagiline Mesylate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Natco Pharma Rasagiline Mesylate Tablets Product Portfolio
  48. 8.8.5 Natco Pharma Recent Developments
  49. 8.9 Lundbeck
  50. 8.9.1 Lundbeck Company Information
  51. 8.9.2 Lundbeck Business Overview
  52. 8.9.3 Lundbeck Rasagiline Mesylate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Lundbeck Rasagiline Mesylate Tablets Product Portfolio
  54. 8.9.5 Lundbeck Recent Developments
  55. 8.10 Intas Pharmaceuticals
  56. 8.10.1 Intas Pharmaceuticals Company Information
  57. 8.10.2 Intas Pharmaceuticals Business Overview
  58. 8.10.3 Intas Pharmaceuticals Rasagiline Mesylate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Intas Pharmaceuticals Rasagiline Mesylate Tablets Product Portfolio
  60. 8.10.5 Intas Pharmaceuticals Recent Developments
  61. 8.11 Apotex
  62. 8.11.1 Apotex Company Information
  63. 8.11.2 Apotex Business Overview
  64. 8.11.3 Apotex Rasagiline Mesylate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Apotex Rasagiline Mesylate Tablets Product Portfolio
  66. 8.11.5 Apotex Recent Developments
  67. 8.12 Alkem Laboratories
  68. 8.12.1 Alkem Laboratories Company Information
  69. 8.12.2 Alkem Laboratories Business Overview
  70. 8.12.3 Alkem Laboratories Rasagiline Mesylate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Alkem Laboratories Rasagiline Mesylate Tablets Product Portfolio
  72. 8.12.5 Alkem Laboratories Recent Developments
  73. 8.13 Ajanta Pharma
  74. 8.13.1 Ajanta Pharma Company Information
  75. 8.13.2 Ajanta Pharma Business Overview
  76. 8.13.3 Ajanta Pharma Rasagiline Mesylate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Ajanta Pharma Rasagiline Mesylate Tablets Product Portfolio
  78. 8.13.5 Ajanta Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Rasagiline Mesylate Tablets Value Chain Analysis
  2. 9.1.1 Rasagiline Mesylate Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Rasagiline Mesylate Tablets Production Mode & Process
  6. 9.2 Rasagiline Mesylate Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Rasagiline Mesylate Tablets Distributors
  9. 9.2.3 Rasagiline Mesylate Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst